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Abstract 
CD34 is a cell surface glycoprotein expressed
by hematopoietic progenitors and endothelial
cells. It is widely used in the clinic for isolation
of human hematopoietic stem cells. In recent
years large animals are gaining increasing
importance in biomedical research for the
study and therapy of human diseases. Sheep
has proved to be an useful experimental model
for preclinical trials in transplantation proce-
dures. Unfortunately, the lack of specie-specific
monoclonal antibodies (MABS) recognizing
hemopoietic progenitor cells hampers the use
of this animal in experimental hematology. The
aim of this paper was to determine whether
commercial monoclonal antibodies specific for
human CD34 molecule could cross-react with
hematopoietic progenitor cells (HPC) present
in sheep umbilical cord blood (UCB). Six anti-
human CD34 MABS, recognizing the three dif-
ferent epitope classes, were tested in flow
cytometry on purified mononuclear cells
(MNC) isolated from cord blood of both species.
None of the MABS used in this trial seemed to
be able to identify HPC from sheep UCB. These
data suggest that the panel of monoclonal anti-
bodies used for cross reactivity detection has to
be expanded with recently produced reagents.
Further studies should be directed towards the
production of ovine specific anti CD34 MABS.
Introduction
CD34 is a transmembrane glycoprotein,
member of the sialomucin family whose phys-
iological roles are still poorly understood
(Lanza et al., 2001). At present, CD34 repre-
sents the only currently known cell surface
antigen able to identify early hematopoietic
progenitor cells of all lineages (Civin et al.,
1984; Krause et al., 1996). The heavily glyco-
sylated cell surface molecule gives rise to a
number of different epitopes (Watt et al.,
1987). Monoclonal antibodies have been rec-
ognized in three classes according to their
epitopes’ recognition and sensitivity to enzy-
matic cleavage with different glycoproteases
(Sutherland et al., 1992). The importance of
CD34 molecule for experimental hematology
is well recognized (Gratama et al., 1998), but
availability of specific monoclonal antibodies
is still limited to few animal species. The sur-
face expression of CD34 antigens is common-
ly used to discriminate between progenitor
cells and mature blood cells in humans
(Andrews et al., 1986; Berenson et al., 1991;
He et al., 1992), nonhuman primates
(Berenson et al., 1988; Izawa et al., 2004),
rodents (Brown et al., 1991; Krause et al.,
1994; Morel et al., 1996; Garlanda et al., 1997)
and dogs (McSweeney et al., 1998; Niemeyer
et al., 2001).
The use of animal models in preclinical tri-
als is fundamental for estimating the safety
and efficacy of innovative treatments such as
cell and gene therapy. Large animals, rather
than commonly used laboratory rodents, allow
a better transposition of biomedical research
results into clinical design. Sheep has been
largely employed to test efficacy of stem cells
transplantation procedures (Menard et al.,
2005; Menasche, 2005; Narayan et al., 2006)
and it is considered an established animal
model for tissue engineering (Erggelet et al.,
2007; Mendelson et al., 2007; Sales et al.,
2007). At the moment, the lack of monoclonal
antibodies recognizing ovine hematopoietic
progenitor cells hampered the use of this ani-
mal for developing new transplantation proce-
dures useful in hematology disorders therapy.
For this reason it is still of considerable value
to test MABS defined in other species for
cross-reactivity. The aim of this study was to
determine by use of flow cytometry analysis
whether monoclonal antibodies specific for
three different epitopes of human CD34 mol-
ecule could identify hemopoietic progenitor
cells in sheep umbilical cord blood.
Materials and methods
Samples of UCB was collected from the
umbilical vein of five sheep undergoing cae-
sarian section and from five women after
vaginal delivery. MNC were isolated in both
species using a density gradient centrifuga-
tion (Hystopaque-1077; Sigma). Cord blood
MNC were analyzed in flow cytometry for cell-
surface expression of CD34 using different
MABS conjugated with phycoerythrin (PE)
recognizing the three different classes of
human epitopes: Immu 133 (class I; IgG1,
Immunotech, Beckman Coulter, Fullerton, CA,
USA), Q-bend/10 (class II; IgG1, Immunotech
Beckman Coulter, Fullerton, CA, USA), 563
(class II; IgG1, BD; San Jose, CA, USA), 8G12
(class III; IgG1, BD, San Jose, CA, USA),
AC136 (class III; IgG1, Miltenyi Biotec,
Bergisch Gladbach, Germany) and 581 (class
III; IgG1, Immunotech Beckman Coulter,
Fullerton, CA, USA). Immu 133, Qbend/10 and
581 MABS were purchased pooled together in
liquid form (CD34 pool). An isotypic control
in order to discriminate for non-specific reac-
tion of the tested MABS (Mouse IgG1-PE,
Beckman Coulter) was used. An amount of
1×106 cells in a 100 µL final volume of each
sample were incubated in dark for 30 minutes
on ice, following manufacturers suggestion
for antibodies dilution: Immu 133, Q-bend/10,
563, 8G12 and 581 MABS were used at 1:5
dilution while AC136 at a dilution of 1:11.
Stained cells were analyzed on a FacsCalibur
(BD) flow cytometer. Thirty thousand events
were acquired for each samples, and analysis
were performed by Cell Quest Pro (BD).
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Results and discussion
To our knowledge, this is the first attempt  to
identify ovine cord blood HPC using human
specific anti-CD34 MABS.
In our experimental conditions, none of the
tested commercial anti-CD34 MABS was able
to recognize sheep cord blood HPC. On the
contrary, analysis of human UCB samples,
used as control, showed that a percentage of
MNC ranging from a low of 0,5% to a high of
2% were CD34 positive, in accordance with
data reported by other authors (D’arena et al.,
1996; Belvedere et al., 1999; Ende et al., 2001)
(Figure 1).
The anti-human CD34 MABS tested in flow
cytometry did not prove to be cross-reacting
with ovine UCB cells, suggesting that CD34
molecule primary and tertiary structure differs
in the two species. Indeed, neither the use of
MABS directed to class I and II linear epitopes,
nor MABS directed to class III conformational
epitopes resulted in a positive reaction.
The choice to test human-specific products
was mainly determined by the availability of
several anti-human MABS clones directed
against the three different CD34 epitopes.
However, the possibility that commercially
available MABS produced for other species
could cross-react with ovine cells should be
considered. Recently, Sakurai et al. (2006)
reported the production of two monoclonal
antibodies against bovine CD34. It might be
expected that anti-CD34 MABS raised against
bovine antigen cross-reacted with ovine cells.
Unfortunately, we were not able to test these
bovine specific MABS since they still were not
commercially available.
Conclusions
In conclusion, our findings suggest that the
number of monoclonal antibodies for cross-
reactivity detection need to be extended with
those of recent production and that further
studies should be directed toward the produc-
tion of specific ovine anti-CD34 MABS.
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